Exploiting ROS and metabolic differences to selectively killing cisplatin resistant lung cancer

被引：0
作者：
Wangpaichitr, Medhi
Wu, Chunjing
Li, Ying Ying
Shah, Sumedh
Chen, Shu-Mei
Dinh, Vy
Kuo, Macus T.
Feun, Lynn G.
Savaraj, Niramol
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1038
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells
    Liang, CH
    Liu, LF
    Shiu, LY
    Huang, YS
    Chang, LC
    Kuo, KW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (03) : 751 - 758
  • [22] An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line
    Kiura, K
    Watarai, S
    Ueoka, H
    Tabata, M
    Gemba, KI
    Aoe, K
    Yamane, H
    Yasuda, T
    Harada, M
    ANTICANCER RESEARCH, 1998, 18 (4C) : 2957 - 2960
  • [23] Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells
    Luo, Yuanyuan
    Yu, Tinghe
    Li, Xinya
    Qian, Guanhua
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [24] Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity
    Wang, Gan
    Wang, Xing
    Xu, Xiaoxin
    BIOMARKER RESEARCH, 2015, 3
  • [25] Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity
    Gan Wang
    Xing Wang
    Xiaoxin Xu
    Biomarker Research, 3 (1)
  • [26] Ovarian cancer patient-derived xenografts resistant to cisplatin exhibit metabolic changes
    Ricci, F.
    Brunelli, L.
    Spriano, F.
    Pastorelli, R.
    Damia, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S46 - S47
  • [27] Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells
    Matsumoto, Nobuki
    Ebihara, Miku
    Oishi, Shiori
    Fujimoto, Yuku
    Okada, Tomoko
    Imamura, Toru
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells
    Nobuki Matsumoto
    Miku Ebihara
    Shiori Oishi
    Yuku Fujimoto
    Tomoko Okada
    Toru Imamura
    Scientific Reports, 11
  • [29] Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study
    Lee, Ronald F. S.
    Riedel, Tina
    Escrig, Stephane
    Maclachlan, Catherine
    Knott, Graham W.
    Davey, Curt A.
    Johnsson, Kai
    Meibom, Anders
    Dyson, Paul J.
    METALLOMICS, 2017, 9 (10) : 1413 - 1420
  • [30] Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy
    Xu, Caina
    Wang, Yanbing
    Guo, Zhaopei
    Chen, Jie
    Lin, Lin
    Wu, Jiayan
    Tian, Huayu
    Chen, Xuesi
    JOURNAL OF CONTROLLED RELEASE, 2019, 295 : 153 - 163
12345